Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - DEPRECIATION & AMORTIZATION
Depreciation & Amortization REGN - Regeneron Pharmaceuticals, Inc.
483 M
LAST VALUE
18.93%
2 YEAR CAGR
18.09%
5 YEAR CAGR
24.80%
10 YEAR CAGR